Quest Diagnostics (DGX) → Stock, financial statements

Quest Diagnostics: stocks, financial statements

Dividends News

Quest Diagnostics, Inc. engages in the provision fo diagnostic testing, information and services. It operates through the Diagnostic Information Services (DIS) and All Other segments. The DIS segment offers diagnostic information services to patients, clinicians, hospitals, health plans, and employers. The All Other segment consists of risk assessment services, healthcare information technology, diagnostic products, and clinical trials testing businesses. The company was founded in 1967 and is headquartered in Secaucus, NJ.

  • DGX Ticker
  • 🇺🇸 NYSE Exchange
  • 46,000 Employees
2 rated

Financial statements — Quest Diagnostics

The information is not 100% up-to-date. There may be errors or missing information. Some information is often missing, and, although there are almost no errors, I can't rule them out. Right now, I'm looking for a supplier of high-quality information, but so far what I'm finding is expensive (about $2000 a year). You can help my project here.
20 ← 16 2020 2019 2018 2017 2016
Total Revenue
9.4B 7.7B 7.5B 7.7B 7.5B
Cost Of Revenue
5.8B 5B 4.9B 4.7B 4.6B
Gross Profit
3.6B 2.7B 2.6B 3B 2.9B
Research and Development
0 0 0 0 0
Selling General and Admin
1.6B 1.5B 1.4B 1.8B 1.7B
Operating Expense
7.5B 6.6B 6.4B 6.5B 6.4B
Operating Income
2B 1.1B 1.1B 1.2B 1.1B
Other Income Expense Net
0 95M 14M -1M 13M
2B 1.3B 1.1B 1.2B 1.2B
Interest Income
160M 180M 170M 150M 140M
Pretax Income
2B 1.1B 970M 1.1B 1.1B
Income Tax
460M 250M 180M 240M 430M
Minority Interest
68M 48M 52M 52M 51M
Net Income
1.4B 860M 730M 770M 640M
Net Income Basic
1.4B 860M 730M 770M 640M
20 ← 16 2020 2019 2018 2017 2016
Current cash
1.2B 1.2B 140M 140M 360M
Short term investments
160M 110M 140M 150M 160M
1.5B 1.1B 1B 920M 930M
220M 120M 99M 95M 82M
Other current assets
160M 110M 140M 150M 160M
Current assets
3.1B 2.5B 1.4B 1.3B 1.5B
Long term investments
11B 10B 9.6B 9.2B 8.6B
Property plant equipment
1.6B 1.5B 1.3B 1.1B 1B
6.9B 6.6B 6.6B 6.3B 6B
Intangible assets
1.2B 1.1B 1.2B 1.1B 950M
Other assets
130M 46M 32M 39M 62M
Total assets
14B 13B 11B 11B 10B
Accounts payable
450M 260M 220M 220M 260M
Current long term debt
160M 890M 560M 110M 6M
Other current liabilities
1.2B 840M 700M 730M 710M
Total current liabilities
1.8B 2B 1.5B 1.1B 980M
Long term debt
4B 4B 3.4B 3.7B 3.7B
Other liabilities
850M 710M 750M 660M 650M
Minority Interest
130M 120M 130M 110M 110M
Total Liabilities
7.3B 7.2B 5.8B 5.6B 5.5B
Common stock
130M 130M 140M 140M 140M
Retained earning
9.3B 8.2B 7.6B 7.1B 6.6B
Treasury stock
-5.4B -5.2B -5B -4.8B -4.5B
Capital surplus
Shareholder equity
6.8B 5.6B 5.2B 4.9B 4.6B
Net tangible assets
-1.3B -2.1B -2.6B -2.5B -2.3B
20 ← 16 2020 2019 2018 2017 2016
Net Income
1.4B 860M 730M 770M 640M
360M 330M 310M 270M 250M
Changes in receivables
460M 51M 88M -2M 25M
Changes in inventories
100M 24M 4M 13M -2M
Cash change
-34M 1.1B -2M -220M 230M
Cash flow
2B 1.2B 1.2B 1.2B 1.1B
Capital expenditures
-420M -400M -380M -250M -290M
Investing activity other
Total investing cash flows
-770M -410M -800M -810M -150M
Dividends paid
Net borrowings
2.9B 3.6B 3.7B 3.6B 3.2B
Other financing cash flows
Cash flow financing
-1.3B 230M -400M -590M -690M
Exchange rate effect